Consolidated Financial Statements Future minimum lease payments reconcile to the net investment in the lease as follows: Sep 30, (in millions of €) 2023 2022 Future minimum lease payments 7,475 7,106 Less: Unearned finance income relating to future minimum lease payments (922) (756) Present value of future minimum lease payments 6,552 6,350 Plus present value of unguaranteed residual value 144 136 Net investment in the lease 6,696 6,486 Investments in finance leases primarily relate to industrial machinery, medical equipment, transportation systems, equipment for information technology and office machines. In fiscal 2023 and 2022, finance income on the net investment in the lease is €372 million and €453 million. NOTE 9 Other current financial assets Sep 30, (in millions of €) 2023 2022 Loans receivable 7,588 6,216 Interest-bearing debt securities 1,047 1,239 Derivative financial instruments 573 957 Other 1,397 1,285 10,605 9,696 NOTE 10 Contract assets and liabilities As of September 30, 2023, and 2022, amounts expected to be settled after twelve months are €1,487 million and €1,321 million for contract assets and €1,812 million and €1,628 million for contract liabilities, respectively. In fiscal 2023, and 2022, revenue includes €7,799 million and €6,158 million, respectively, which was included in contract liabilities at the beginning of the fiscal year. NOTE 11 Inventories and Other current assets Inventories Sep 30, (in millions of €) 2023 2022 Raw materials and supplies 3,516 3,197 Work in progress 4,029 3,631 Finished goods and products held for resale 3,715 3,419 Advances to suppliers 287 379 11,548 10,626 Cost of sales includes inventories recognized as expense amounting to €47,350 million and €45,159 million, respectively, in fiscal 2023 and 2022. Compared to prior year, write-downs increased by €131 million in fiscal 2023. In fiscal 2022, write-downs increased by €94 million compared to fiscal 2021. Other current assets In fiscal 2023, and 2022, Other current assets include other tax receivables of €784 million and €810 million, prepaid expenses of €543 million and €509 million, respectively, and €283 million and €261 million, respectively, in reimbursement claims relating to activities in Russia. 16